C
Centrillion Biosciences
Develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics
About Centrillion Biosciences
Centrillion Technologies, formerly known as Centrillion Biosciences, is a life sciences company that has developed a range of genomics and DNA analysis technologies. The company focuses on creating tools for genomic studies, which include sequencing, bioinformatics solutions, and a new generation of DNA chips. These chips are designed to be compatible with sequencing and combine high-density with high-quality probes, addressing critical issues in large-scale genomic analysis.
Centrillion serves clients in the drug discovery and life sciences research sectors. Its business model is centered on providing these tools and services to other businesses and research institutions. The company generates revenue through the sale of its products, such as the ATOM™, a high-throughput detection system, and the VirusHunter™ MVP assay for detecting pathogens like SARS-CoV-2 and Influenza. Additionally, Centrillion offers molecular and genomics services, including sequencing and droplet digital PCR, further supporting its B2B model.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Palo Alto, United States
- Employees
- 53
- Open positions
- None listed
- Dealroom signal
- 70.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Precision Medicine, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Other✓Other financing | Aug 2018 | $0 | — | ARM | — |
| SERIES B✓Equity / VC | Apr 2013 | $9M | $36M | Undisclosed | — |
Growth signals
Latest recorded traffic for Centrillion Biosciences is 8.8K monthly website visits, up 911.5% over the last three months. Centrillion Biosciences's team grew 6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors5 additional known investors
ARM
CLI Ventures
Cybernaut Zfounder Ventures,
GRC SinoGreen Fund
SV Tech Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Centrillion Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Centrillion Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.